In this study, we tested the hypotheses that (a) functional antibodies targeting NBCn1 can be developed for specific pharmacological inhibition and (b) NBCn1 is responsible for the Na+,HCO3–-cotransport in human breast cancer tissue and can be targeted for breast cancer therapy. The gene discussed is XK; the disease is breast cancer.